Early inhibition of TNFα increases 6-hydroxydopamine-induced striatal degeneration

Brain Research

Volumn 1147, Issue 1, 2007, Pages 240-247

  Gemma, Carmelina ^a,b   Catlow, Briony ^b   Cole, Michael ^b   Hudson, Charles ^a   Samec, Amy ^b   Shah, Nishan ^b   Vila, Jennifer ^b,c   Bachstetter, Adam ^b   Bickford, Paula C ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

6 Hydroxydopamine; Cytokines; Microglia; Neuroinflammation; Parkinson's disease; Tumor necrosis factor

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; OXIDOPAMINE; TUMOR NECROSIS FACTOR ALPHA; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN DEGENERATION; CONTROLLED STUDY; CORPUS STRIATUM; DRUG INHIBITION; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; DRUG EFFECT; FISCHER 344 RAT; IMMUNOHISTOCHEMISTRY; METABOLISM; NEOSTRIATUM; NERVE DEGENERATION; PARKINSONISM; PATHOLOGY; TIME;

RATTUS;

ANIMALS; IMMUNOHISTOCHEMISTRY; MALE; NEOSTRIATUM; NERVE DEGENERATION; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, INBRED F344; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34247158086     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.02.003     Document Type: Article

References (31)

1. Aloe L., and Fiore M. TNF-alpha expressed in the brain of transgenic mice lowers central tyroxine hydroxylase immunoreactivity and alters grooming behavior. Neurosci. Lett. 238 (1997) 65-68
2. Banati R.B., Daniel S.E., and Blunt S.B. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease. (see comments). Mov. Disord. 13 (1998) 221-227
3. Bradt B.M., Kolb W.P., and Cooper N.R. Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptide. J. Exp. Med. 188 (1998) 431-438
4. Duffield J.S. The inflammatory macrophage: a story of Jekyll and Hyde. Clin. Sci. (Lond) 104 (2003) 27-38
5. Edwards M.M., and Robinson S.R. TNF alpha affects the expression of GFAP and S100B: implications for Alzheimer's disease. J. Neural. Transm. 113 (2006) 1709-1715
6. Fontaine V., Mohand-Said S., Hanoteau N., Fuchs C., Pfizenmaier K., and Eisel U. Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J. Neurosci. 22 (2002) RC216
7. Gao H.M., Jiang J., Wilson B., Zhang W., Hong J.S., and Liu B. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J. Neurochem. 81 (2002) 1285-1297
8. Griffin W.S. Inflammation and neurodegenerative diseases. Am. J. Clin. Nutr. 83 (2006) 470S-474S
9. He Y., Appel S., and Lee W. Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Res. 909 (2001) 187-193
10. Hirsch E.C., Hunot S., Damier P., and Faucheux B. Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration?. Ann. Neurol. 44 (1998) S115-S120
11. Kuno R., Yoshida Y., Nitta A., Nabeshima T., Wang J., Sonobe Y., Kawanokuchi J., Takeuchi H., Mizuno T., and Suzumura A. The role of TNF-alpha and its receptors in the production of NGF and GDNF by astrocytes. Brain Res. 1116 (2006) 12-18
12. Ling Z., Gayle D.A., Ma S.Y., Lipton J.W., Tong C.W., Hong J.S., and Carvey P.M. In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Mov. Disord. 17 (2002) 116-124
13. Loddick S.A., and Rothwell N.J. Mechanisms of tumor necrosis factor alpha action on neurodegeneration: interaction with insulin-like growth factor-1. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 9449-9451
14. Mantovani A., Sozzani S., Locati M., Allavena P., and Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23 (2002) 549-555
15. Mayne M., Ni W., McKenna R., and Power C. Antisense oligodeoxynucleotides targeting internal exon sequences efficiently regulate TNF-alpha expression. Antisense Nucleic Acid Drug Dev. 9 (1999) 135-144
16. Mayne M., Ni W., Yan H.J., Xue M., Johnston J.B., Del Bigio M.R., Peeling J., and Power C. Antisense oligodeoxynucleotide inhibition of tumor necrosis factor-alpha expression is neuroprotective after intracerebral hemorrhage. Stroke 32 (2001) 240-248
17. McGeer E.G., and McGeer P.L. The role of the immune system in neurodegenerative disorders. (Review) (25 refs). Mov. Disord. 12 (1997) 855-858
18. McGeer P.L., Akiyama H., Itagaki S., and McGeer E.G. Immune system response in Alzheimer's disease. Can J. Neurol. Sci. 16 (1989) 516-527
19. McGuire S.O., Ling Z.D., Lipton J.W., Sortwell C.E., Collier T.J., and Carvey P.M. Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons. Exp. Neurol. 169 (2001) 219-230
20. Mladenovic A., Perovic M., Raicevic N., Kanazir S., Rakic L., and Ruzdijic S. 6-Hydroxydopamine increases the level of TNFalpha and bax mRNA in the striatum and induces apoptosis of dopaminergic neurons in hemiparkinsonian rats. Brain Res. 996 (2004) 237-245
21. Mogi M., Harada M., Riederer P., Narabayashi H., Fujita K., and Nagatsu T. Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci. Lett. 165 (1994) 208-210
22. Nagatsu T., Mogi M., Ichinose H., and Togari A. Cytokines in Parkinson's disease. J. Neural Transm. Suppl. (2000) 143-151
23. Rogers J., Strohmeyer R., Kovelowski C.J., and Li R. Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia 40 (2002) 260-269
24. Rousselet A., Fetler L., Chamak B., and Prochiantz A. Rat mesencephalic neurons in culture exhibit different morphological traits in the presence of media conditioned on mesencephalic or striatal astroglia. Dev. Biol. 129 (1988) 495-504
25. Rousselet E., Callebert J., Parain K., Joubert C., Hunot S., Hartmann A., Jacque C., Perez-Diaz F., Cohen-Salmon C., Launay J.M., and Hirsch E.C. Role of TNF-alpha receptors in mice intoxicated with the parkinsonian toxin MPTP. Exp. Neurol. 177 (2002) 183-192
26. Sauer H., and Oertel W.H. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59 (1994) 401-415
27. Shinpo K., Kikuchi S., Moriwaka F., and Tashiro K. Protective effects of the TNF-ceramide pathway against glutamate neurotoxicity on cultured mesencephalic neurons. Brain Res. 819 (1999) 170-173
28. Sriram K., Matheson J.M., Benkovic S.A., Miller D.B., Luster M.I., and O'Callaghan J.P. Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease. FASEB J. 16 (2002) 1474-1476
29. Streit W.J., Conde J.R., Fendrick S.E., Flanary B.E., and Mariani C.L. Role of microglia in the central nervous system's immune response. Neurol. Res. 27 (2005) 685-691
30. West M.J., Slomianka L., and Gundersen H.J. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat. Rec. 231 (1991) 482-497
31. Yang L., Lindholm K., Konishi Y., Li R., and Shen Y. Target depletion of distinct tumor necrosis factor receptor subtypes reveals hippocampal neuron death and survival through different signal transduction pathways. J. Neurosci. 22 (2002) 3025-3032